Close Menu

Here in Marco Island, Fla., giant jellyfish may have claimed the beach, but genome scientists have taken charge of the local Marriott hotel for the annual Advances in Genome Biology & Technology conference. While Thursday was the first official day of the event, Wednesday's pre-meeting workshop on next-gen sequencing was every bit as jam-packed as the rest of the sessions so far. Richard Gibbs from Baylor offered an overview of the market as it stands right now, noting that alongside the impressive performance of many of these machines still comes a lot of hype about what's possible.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.